跳至主要内容
临床试验/NL-OMON45699
NL-OMON45699已完成不适用

Intraperitoneal infusion of ex vivo cultured allogeneic Natural Killer cells in recurrent ovarian carcinoma patients. - INTRO

Radboud Universitair Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Patient with a second recurrence of ovarian cancer, based on increasing CA-125 levels, without symptoms. Patients are included after palliative chemotherapy for their first recurrence. Patients must have a life expectancy of >6 months and are only enrolled after prior given written informed consent. Patients should be able to undergo a laparoscopy.

排除标准

  • Patients with active infections or serious organ failure are excluded. Patients on immunesuppressive drugs and with recent chemotherapy (<28days ago).

研究者

相似试验